|
bioMérieux is a maker of "in vitro" diagnostics with a focus on infectious diseases. The French company makes instrument systems and chemical reagents used by clinical laboratories to test for infections such as sepsis, tuberculosis, hospital-acquired infections, and AIDS, as well as for cancers and cardiovascular conditions. It also makes industrial tests that food, cosmetics, and drug companies use to check their products for harmful bacteria and other microorganisms. bioMérieux sells its products in more than 150 countries. The company got its start in 1897 when Louis Pasteur's assistant, Marcel Mérieux, founded the Institut Mérieux to develop vaccines and reagents; the Mérieux family still controls the firm.
|
| | | Contact Information | |
Address: |
5, rue des Aqueducs, BP 10
69290 Craponne, France
| | Phone: | +33-0-820-22-3000 | | Fax: | +33-0-820-22-5000 |
|
| Financial
Highlights | | Fiscal Year End: | September | | Revenue (2008): | 1565.20 M | | Revenue Growth (1 yr): | 0.10% |
|
|
Key People
| | • |
Chairman:
Alain Mérieux
| | • |
CEO:
Stéphane Bancel
| | • |
VP Commercial Operations:
Thierry Bernard
|
|
|
